文献速递术前评估与围术期医学

舒更葡糖与格隆溴铵新斯的明在严重肾功能不全患者神经肌肉阻滞逆转中的随机双盲研究

Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study.
PubMed 文献 · Anesth Analg · 2024-01-08

这项前瞻性随机双盲对照试验在49例严重肾功能不全(肌酐清除率<30 mL/min)患者中比较罗库溴铵+舒更葡糖与顺阿曲库铵+新斯的明逆转神经肌肉阻滞的效果,发现舒更葡糖组TOFR≥90%恢复时间平均3.5分钟,显著快于新斯的明组的14.8分钟(P<.0001),两组均无重大不良事件。

要点

  • 严重肾功能不全患者使用舒更葡糖逆转罗库溴铵阻滞恢复更快
  • 舒更葡糖组TOFR≥90%平均时间3.5分钟,新斯的明组14.8分钟
  • 两组均未发生重大不良事件

核心结论

  • 在严重肾功能不全患者中,罗库溴铵+舒更葡糖逆转神经肌肉阻滞比顺阿曲库铵+新斯的明恢复更快且无重大不良事件。

研究设计与样本

  • 前瞻性、随机、盲法、对照试验,在大型县医院进行,共纳入49例年龄≥18岁、ASA III-IV级、肌酐清除率<30 mL/min、预计手术时间≥2小时且需要神经肌肉阻滞的患者。

主要发现

  • 舒更葡糖组TOFR≥90%恢复时间平均3.5(±1.6)分钟,新斯的明组14.8(±6.1)分钟,平均差异11.3分钟(95%CI 9.0-13.5分钟),P<.0001。
  • 两组均无重大不良事件。

关键数值与推荐

  • 舒更葡糖剂量2 mg/kg,新斯的明剂量50 µg/kg联合格隆溴铵10 µg/kg。
  • 主要结局为TOFR≥90%的恢复时间,使用肌电图(TwitchView)每分钟记录。

临床怎么用

  • 对于严重肾功能不全需神经肌肉阻滞的患者,可考虑使用罗库溴铵诱导并以舒更葡糖2 mg/kg逆转,以加快恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sugammadex is not advised for patients with severe renal impairment, but has been shown in a variety of other populations to be superior to neostigmine for reversal of neuromuscular blockade. The objective of this study was to determine if reversal of rocuronium-induced neuromuscular blockade with sugammadex versus reversal of cisatracurium-induced neuromuscular blockade with neostigmine results in a faster return to a train-of-four ratio (TOFR) ≥90% in patients with severe renal impairment. METHODS: We conducted a prospective, randomized, blinded, controlled trial at a large county hospital. A total of 49 patients were enrolled. Inclusion criteria included patients age ≥18, American Society of Anesthesiologists (ASA) physical status III and IV, with a creatinine clearance <30 mL/min, undergoing general anesthesia with expected surgical duration ≥2 hours and necessitating neuromuscular blockade. Subjects received either cisatracurium 0.2 mg/kg or rocuronium 0.6 mg/kg for induction of anesthesia to facilitate tracheal intubation. Subjects were kept at moderate neuromuscular blockade during surgery and received either 2 mg/kg sugammadex or 50 µg/kg neostigmine with 10 µg/kg glycopyrrolate for reversal of neuromuscular blockade. Neuromuscular monitoring was performed with electromyography (TwitchView), and the TOFR was recorded every minute after administration of the reversal agent. The time from administration of neuromuscular reversal until the patient reached a TOFR ≥90% was recorded as the primary outcome. RESULTS: The mean time to recovery of TOFR ≥90% was significantly faster with sugammadex at 3.5 (±1.6) min compared with neostigmine at 14.8 (±6.1) min ( P < .0001; mean difference, 11.3 minutes; 95% confidence interval [CI], 9.0-13.5 minutes). There were no major adverse events in either group. CONCLUSIONS: In patients with severe renal impairment, neuromuscular blockade with rocuronium followed by reversal with sugammadex provides a significantly faster return of neuromuscular function compared to cisatracurium and neostigmine, without any major adverse effects.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Oh MW, Mohapatra SG, Pak T, et al. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study. Anesth Analg. 2024. PMID: 38190344. doi:10.1213/ANE.0000000000006807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。